Bloomington Becomes Backdrop For Film

Posted: Updated:
The film will shoot in Bloomington until mid-February. The film will shoot in Bloomington until mid-February.
BLOOMINGTON -

Filming has begun in Bloomington for a romantic comedy produced by two Indiana University alumni. The Good Catholic is being made by Pigasus Pictures, which is owned by Zach Spicer and John Armstrong.

Faculty and staff newsletter Inside IU reports Spicer will star in the film along with actors Danny Glover and John C. McGinley. The film was written and is being directed by IU alum Paul Shoulberg. David Anspaugh, who directed Hoosiers and Rudy, will serve as executive producer.

"We want to bring great film back to the state of Indiana," Spicer told Inside IU. "The only way we’ve been able to put this film together is because of the great story at the heart of it all and the great people we’ve been able to get onboard because of it. To top it off, there is no better setting than the streets of Bloomington."

Spicer, who graduated from IU in 2006, is a native of Greencastle. Armstrong, a native of Brownsburg, received his bachelor's degree in musical theater in 2002 and MFA in acting in 2007.

The Good Catholic is scheduled to continue filming in downtown Bloomington until February 13.

  • Perspectives

    • How Managers Can Keep Millennials Happy

      There are more than 56 million Millennials either actively participating in the workforce, or searching for a job. With a number like this, it’s no surprise that Millennials have taken the workplace by storm. But what is surprising is how different this generation is from their predecessors. They rely heavily on technology and prefer to communicate via text or email rather than a traditional phone call. Managing millennial employees can be a challenge — how can executives...

    More

Events



  • Most Popular Stories

    • $25M Behavioral Hospital Coming to Central Indiana

      Danville-based Hendricks Regional Health is partnering with US HealthVest to develop a stand-alone behavioral center on the Hendricks campus in Plainfield. Known as the Indianapolis Behavioral Hospital, the facility will provide specialized inpatient and outpatient mental health care to patients of all ages.

    • How Managers Can Keep Millennials Happy

      There are more than 56 million Millennials either actively participating in the workforce, or searching for a job. With a number like this, it’s no surprise that Millennials have taken the workplace by storm. But what is surprising is how different this generation is from their predecessors. They rely heavily on technology and prefer to communicate via text or email rather than a traditional phone call. Managing millennial employees can be a challenge — how can executives...

    • Christel DeHaan to Retire as Christel House CEO

      One of the biggest names in philanthropy in Indiana is announcing her retirement. Christel House International Chief Executive Officer Christel DeHaan will remain board chair, but leave as CEO of the nonprofit she founded 20 years ago. The organization has named former Indianapolis Mayor Bart Peterson to be her successor. CHI's mission is to lift children out of poverty, and it has established learning centers at home in Indianapolis and abroad in Mexico, India, South Africa and...

    • Sturges, CBRE Splitting Up

      A long-time commercial real estate firm in Fort Wayne is going independent. CBRE | Sturges, which became affiliated with the global brand more than 20 years ago, will become Sturges Property Group at the end of this month. The firm was founded in 1975 and bills itself as largest full-service commercial and industrial real estate firm in the region. The shift, Sturges says, will...

    • Endocyte, Novartis Ink $2.1B Merger Agreement

      West Lafayette-based Endocyte Inc. (Nasdaq: ECYT) has announced a merger agreement with a global pharmaceutical giant. The deal with Switzerland-based Novartis AG is valued at $2.1 billion and still requires shareholder approval. Until regulatory and other approvals are met, Endocyte will remain independent. The proposed merger of Endocyte into Novartis is slated to be complete in the first half of next year. Endocyte develops targeted cancer therapies and earlier this...